Back to search

Peptide record

TPDB11069

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
28 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11069
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb dbAMP
standard
No
A 28-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, ACP740 _ACP240, and other sources, with an available 3D structural model.
Sequence
ATAVDFGPHGLLPIRPIRIRPLCGKDKS
Physicochemical Analysis
C136H227N41O35S1
NEQMWY
P
3028.61
10.57
6
2
10
+3
5.68
-0.093
101.07
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
2
A
3
R
0
N
2
D
1
C
0
E
0
Q
3
G
1
H
3
I
3
L
2
K
0
M
1
F
4
P
1
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 3 N: 0 D: 2 C: 1 E: 0 Q: 0 G: 3 H: 1 I: 3 L: 3 K: 2 M: 0 F: 1 P: 4 S: 1 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
28
C136H227N41O35S1
3028.61
10.57
+3
5.68
-0.093
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
9.4 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
4.7 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 3 Activity

Activity

MIC
Antibacterial
75 µg/mL

Target

B. subtilis

Source & Reference

dbAMP

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 4 Activity

Activity

MIC
Antibacterial
18.8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP

Other

ainst E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 5 Activity

Activity

MIC
Antifungal
9.4 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
4.7 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 7 Activity

Activity

MIC
Antifungal
75 µg/mL

Target

B. subtilis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 8 Activity

Activity

MIC
Antifungal
18.8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ainst E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 9 Activity

Activity

MIC
Antiparasitic
9.4 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml).
Evidence 10 Activity

Activity

MIC
Antiparasitic
4.7 µg/mL

Target

Staphylococcus aureus

Source & Reference

NA

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 11 Activity

Activity

MIC
Antiparasitic
75 µg/mL

Target

B. subtilis

Source & Reference

NA

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 12 Activity

Activity

MIC
Antiparasitic
18.8 µg/mL

Target

Candida albicans

Source & Reference

NA

Other

ainst E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 13 Activity

Activity

MIC
Antiviral
9.4 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml).
Evidence 14 Activity

Activity

MIC
Antiviral
4.7 µg/mL

Target

Staphylococcus aureus

Source & Reference

NA

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 15 Activity

Activity

MIC
Antiviral
75 µg/mL

Target

B. subtilis

Source & Reference

NA

Other

active against E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.
Evidence 16 Activity

Activity

MIC
Antiviral
18.8 µg/mL

Target

Candida albicans

Source & Reference

NA

Other

ainst E. coli (MIC 9.4 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 75 ug/ml), and C. albicans (MIC 18.8 ug/ml). Aslo histamine release.